Your browser doesn't support javascript.
loading
Impaired Proteolysis of Noncanonical RAS Proteins Drives Clonal Hematopoietic Transformation.
Chen, Sisi; Vedula, Rahul S; Cuevas-Navarro, Antonio; Lu, Bin; Hogg, Simon J; Wang, Eric; Benbarche, Salima; Knorr, Katherine; Kim, Won Jun; Stanley, Robert F; Cho, Hana; Erickson, Caroline; Singer, Michael; Cui, Dan; Tittley, Steven; Durham, Benjamin H; Pavletich, Tatiana S; Fiala, Elise; Walsh, Michael F; Inoue, Daichi; Monette, Sebastien; Taylor, Justin; Rosen, Neal; McCormick, Frank; Lindsley, R Coleman; Castel, Pau; Abdel-Wahab, Omar.
Afiliação
  • Chen S; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Vedula RS; Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Cuevas-Navarro A; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California.
  • Lu B; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Hogg SJ; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Wang E; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Benbarche S; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Knorr K; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Kim WJ; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Stanley RF; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Cho H; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Erickson C; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Singer M; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Cui D; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Tittley S; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Durham BH; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Pavletich TS; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Fiala E; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Walsh MF; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Inoue D; Department of Hematology-Oncology, Institute of Biomedical Research and Innovation, Foundation for Biomedical Research and Innovation at Kobe, Kobe, Japan.
  • Monette S; Laboratory of Comparative Pathology, Memorial Sloan Kettering Cancer Center, Weill Cornell Medicine, The Rockefeller University, New York, New York.
  • Taylor J; Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine, Miami, Florida.
  • Rosen N; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York.
  • McCormick F; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California.
  • Lindsley RC; Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Castel P; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California.
  • Abdel-Wahab O; Department of Biochemistry and Molecular Pharmacology, New York University Grossman School of Medicine, New York, New York.
Cancer Discov ; 12(10): 2434-2453, 2022 10 05.
Article em En | MEDLINE | ID: mdl-35904492

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia / Proteínas ras Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Cancer Discov Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia / Proteínas ras Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Cancer Discov Ano de publicação: 2022 Tipo de documento: Article